Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Pharmacoeconomics
|
May 5, 2018
Review of Economic Value Drivers of the Treatment of Overactive Bladder
Sonya J Snedecor
AIDS Research and Human Retroviruses
|
June 16, 2021
Short Communication: Prevalence of Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors in European and North American Countries Over 20 Years: An Updated Meta-Analysis
Sonya J Snedecor
Bulletin of Mathematical Biology
|
July 12, 2005
Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression
Sonya J Snedecor
Journal of Theoretical Biology
|
April 26, 2003
Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment
Sonya J Snedecor
Postgraduate Medicine
|
February 22, 2021
Potential public health impact of a <i>Neisseria meningitidis</i> A, B, C, W, and Y pentavalent vaccine in the United States
Liping Huang, Sonya J Snedecor, Paul Balmer, et al.
Pharmaceutical Research
|
July 13, 2006
Feasibility of weekly HIV drug delivery to enhance drug localization in lymphoid tissues based on pharmacokinetic models of lipid-associated indinavir
Sonya J Snedecor, Sean M Sullivan, Rodney J Y Ho
Journal of Medical Economics
|
October 22, 2015
Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States
Lei Qin, Xuemei Luo, Kelly H Zou, et al.
Sleep
|
May 16, 2019
Multiple treatment comparison in narcolepsy: a network meta-analysis-methodological concerns
Sonya J Snedecor, Geert Mayer, Michael J Thorpy, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 24, 2015
Associations between signs and symptoms of dry eye disease: a systematic review
Jimmy D Bartlett, Michael S Keith, Lavanya Sudharshan, et al.
BMC Infectious Diseases
|
May 5, 2022
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
Vasiliki Chounta, Sonya J Snedecor, Sterling Wu, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Pharmacoeconomics
|
May 5, 2018
Review of Economic Value Drivers of the Treatment of Overactive Bladder
Sonya J Snedecor
AIDS Research and Human Retroviruses
|
June 16, 2021
Short Communication: Prevalence of Transmitted Resistance to Non-Nucleoside Reverse Transcriptase Inhibitors in European and North American Countries Over 20 Years: An Updated Meta-Analysis
Sonya J Snedecor
Bulletin of Mathematical Biology
|
July 12, 2005
Dynamic treatment model to examine the association between phenotypic drug resistance and duration of HIV viral suppression
Sonya J Snedecor
Journal of Theoretical Biology
|
April 26, 2003
Comparison of three kinetic models of HIV-1 infection: implications for optimization of treatment
Sonya J Snedecor
Postgraduate Medicine
|
February 22, 2021
Potential public health impact of a <i>Neisseria meningitidis</i> A, B, C, W, and Y pentavalent vaccine in the United States
Liping Huang, Sonya J Snedecor, Paul Balmer, et al.
Pharmaceutical Research
|
July 13, 2006
Feasibility of weekly HIV drug delivery to enhance drug localization in lymphoid tissues based on pharmacokinetic models of lipid-associated indinavir
Sonya J Snedecor, Sean M Sullivan, Rodney J Y Ho
Journal of Medical Economics
|
October 22, 2015
Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States
Lei Qin, Xuemei Luo, Kelly H Zou, et al.
Sleep
|
May 16, 2019
Multiple treatment comparison in narcolepsy: a network meta-analysis-methodological concerns
Sonya J Snedecor, Geert Mayer, Michael J Thorpy, et al.
Clinical Ophthalmology (Auckland, N.Z.)
|
September 24, 2015
Associations between signs and symptoms of dry eye disease: a systematic review
Jimmy D Bartlett, Michael S Keith, Lavanya Sudharshan, et al.
BMC Infectious Diseases
|
May 5, 2022
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
Vasiliki Chounta, Sonya J Snedecor, Sterling Wu, et al.
Page
of 4